Please login to the form below
Translate Bio
This page shows the latest Translate Bio news and features for those working in and with pharma, biotech and healthcare.
Sanofi to pay $1.2bn to acquire Amunix and its ‘stealth’ technology
In September the company completed its $3.2bn purchase of Translate Bio, aimed at bolstering its vaccines and mRNA capabilities, while in November it paid $1.9bn for Kadmon to strengthen
Latest news
-
Merck’s $11.5bn acquisition of Acceleron delayed
This is not the first time a major pharma company has had to refile a premerger notice; Sanofi did it when acquiring Translate Bio, and AstraZeneca refiled the notification during an
-
Sanofi sees double-digit growth driven by ‘megabrand’ Dupixent
With higher R&D investment behind our pipeline assets and the two targeted bolt-on acquisitions of Translate Bio and Kadmon, we have further increased our commitment to bring innovative medicines
-
Sanofi refocuses COVID-19 efforts away from mRNA
The data “confirms the potential” of the mRNA and lipid nanoparticle platform Sanofi acquired from Translate Bio, and also “supports Sanofi’s mRNA strategy”, said the company.
-
AstraZeneca invests in RNA tech platform
In August, Sanofi added Translate Bio’s mRNA platform to its pipeline and now it’s the turn of AstraZeneca (AZ).
-
Sanofi boosts transplant portfolio with newly approved Rezurock
Kadmon is Sanofi’s third acquisition this year. In July it acquired Translate Bio and its mRNA technology while in April it completed it acquisition of Kiadis and its immune-oncology
More from news
Approximately 4 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.
-
Developing a COVID-19 vaccine
The second agreement, with Translate Bio, will focus on developing an mRNA vaccine for COVID-19. ... Translate has already begun to produce multiple mRNA constructs and will use its platform to discover, design and manufacture a number of coronavirus
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Ann Barbier joins Translate Bio as its chief medical officer
US-based biotech Translate Bio has appointed Ann Barbier as its new chief medical officer. ... She said: “With near-term clinical programmes in cystic fibrosis and OTC deficiency, Translate Bio is approaching a critical and exciting time.
-
US biotech Translate Bio appoints Daniella Beckman
She joins the board of directors. Translate Bio has appointed Daniella Beckman to its board of directors and she will also serve at the US biotech as chairperson of its ... Ronald Renaud, chief executive officer, Translate Bio, said: “Daniella joins
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- Creabilis names Catherine Moukheibir as chairman of the board
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- MIT researchers develop AI model to detect future lung cancer risk
- World Health Organization releases latest set of COVID-19 guidelines
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
